{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:28:26Z","timestamp":1766435306619,"version":"3.48.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,22]]},"DOI":"10.7759\/cureus.99855","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:57:22Z","timestamp":1766426242000},"source":"Crossref","is-referenced-by-count":0,"title":["Cervical Cancer Outcomes and Toxicity in HIV-Positive Women Treated With Radiation or Chemoradiation: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Florence","family":"Mutua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheen","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuraag","family":"Shrivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranya","family":"Kakumanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhay","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). the urgency of now: AIDS at a crossroads. (2024). Accessed: June 22, 2025: https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford GM","year":"2006","unstructured":"Clifford GM, Gon\u00e7alves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006, 20:2337-44. 10.1097\/01.aids.0000253361.63578.14","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu G","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018, 32:795-808. 10.1097\/QAD.0000000000001765","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000455","article-title":"Long-term cumulative detection of human papillomavirus among HIV seropositive women","volume":"28","author":"Massad LS","year":"2014","unstructured":"Massad LS, Xie X, Burk R, et al.. Long-term cumulative detection of human papillomavirus among HIV seropositive women. AIDS. 2014, 28:2601-8. 10.1097\/QAD.0000000000000455","journal-title":"AIDS"},{"key":"ref6","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1,2018). Accessed: March 23, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30440-0","article-title":"Radiotherapy in patients with HIV: current issues and review of the literature","volume":"18","author":"Alongi F","year":"2017","unstructured":"Alongi F, Giaj-Levra N, Sciascia S, et al.. Radiotherapy in patients with HIV: current issues and review of the literature. Lancet Oncol. 2017, 18:379-93. 10.1016\/S1470-2045(17)30440-0","journal-title":"Lancet Oncol"},{"key":"ref8","unstructured":"International Atomic Energy Agency. management of cervical cancer: strategies for limited-resource centres - a guide for radiation oncologists. (2013). Accessed: May 31, 2025: http:\/\/pub.iaea.org\/MTCD\/Publications\/PDF\/Pub1556_web.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein PG","year":"2014","unstructured":"Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges. AIDS. 2014, 28:453-65. 10.1097\/QAD.0000000000000071","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.07.002","article-title":"NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients","volume":"116","author":"Ulrike K","year":"2015","unstructured":"Ulrike K, Markus H, Thomas H, Ellen H, Barbara S, Rainer F, Distel LV. NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients. Radiother Oncol. 2015, 116:323-30. 10.1016\/j.radonc.2015.07.002","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104519","article-title":"Current management of cervical cancer in women living with HIV","volume":"204","author":"Beas-Lozano EL","year":"2024","unstructured":"Beas-Lozano EL, Contreras S, Donald-Jaramillo MA, Frayde-Aguilar C, Carrillo-Vidales J, Jaime-Casas S, Martinez-Cannon BA. Current management of cervical cancer in women living with HIV. Crit Rev Oncol Hematol. 2024, 204:104519. 10.1016\/j.critrevonc.2024.104519","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00312","article-title":"Outcomes of cervical cancer in HIV-positive women treated with radiotherapy at a tertiary care center in India","volume":"8","author":"Gurram L","year":"2022","unstructured":"Gurram L, Mohanty S, Chopra S, et al.. Outcomes of cervical cancer in HIV-positive women treated with radiotherapy at a tertiary care center in India. JCO Glob Oncol. 2022, 8:e2100312. 10.1200\/GO.21.00312","journal-title":"JCO Glob Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.04.007","article-title":"Differences in outcomes of chemoradiation in women with invasive cervical cancer by human immunodeficiency virus status: a systematic review","volume":"11","author":"Shah S","year":"2021","unstructured":"Shah S, Xu M, Mehta P, Zetola NM, Grover S. Differences in outcomes of chemoradiation in women with invasive cervical cancer by human immunodeficiency virus status: a systematic review. Pract Radiat Oncol. 2021, 11:53-65. 10.1016\/j.prro.2020.04.007","journal-title":"Pract Radiat Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)","author":"Cochrane Collaboration","year":"2022","unstructured":"Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (ed): 2022. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4086","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"354","year":"2016","unstructured":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015. elaboration and explanation. BMJ. 2016, 354:i4086. 10.1136\/bmj.i4086","journal-title":"BMJ"},{"key":"ref17","unstructured":"Veritas Health Innovation. Covidence - Better systematic review management. Melb. Verit. Heal. Innov. (2024). https:\/\/www.covidence.org\/.."},{"key":"ref18","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2011). Accessed: July 21, 2025: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref19","unstructured":"The Cochrane Collaboration 2020. Review Manager (RevMan), version 5.4. (2020). http:\/\/revman.cochrane.org\/."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/21925682221110527","article-title":"Fixed-effect vs random-effects models for meta-analysis: 3 points to consider","volume":"12","author":"Dettori JR","year":"2022","unstructured":"Dettori JR, Norvell DC, Chapman JR. Fixed-effect vs random-effects models for meta-analysis: 3 points to consider. Global Spine J. 2022, 12:1624-6. 10.1177\/21925682221110527","journal-title":"Global Spine J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.09.021","article-title":"Multiple uses of forest plots in presenting analysis results in health research: a tutorial","volume":"117","author":"Li G","year":"2020","unstructured":"Li G, Zeng J, Tian J, Levine MA, Thabane L. Multiple uses of forest plots in presenting analysis results in health research: a tutorial. J Clin Epidemiol. 2020, 117:89-98. 10.1016\/j.jclinepi.2019.09.021","journal-title":"J Clin Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00360","article-title":"A retrospective analysis of the impact of HIV Infection on outcomes of locally advanced cervical cancers treated with either conventional or hypofractionated radiotherapy: the Uganda experience","volume":"8","author":"Kavuma A","year":"2022","unstructured":"Kavuma A, Luutu I, Kibudde S, Kanyike D. A retrospective analysis of the impact of HIV Infection on outcomes of locally advanced cervical cancers treated with either conventional or hypofractionated radiotherapy: the Uganda experience. JCO Glob Oncol. 2022, 8:e2100360. 10.1200\/GO.21.00360","journal-title":"JCO Glob Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4314\/eamj.v83i8.9455","article-title":"Effect of HIV serological status on outcome in patients with cancer of cervix treated with radiotherapy","volume":"83","author":"Kigula-Mugambe JB","year":"2006","unstructured":"Kigula-Mugambe JB, Kavuma A. Effect of HIV serological status on outcome in patients with cancer of cervix treated with radiotherapy. East Afr Med J. 2006, 83:416-23. 10.4314\/eamj.v83i8.9455","journal-title":"East Afr Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9613","article-title":"HIV infection and survival among women with cervical cancer","volume":"34","author":"Dryden-Peterson S","year":"2016","unstructured":"Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, et al.. HIV infection and survival among women with cervical cancer. J Clin Oncol. 2016, 34:3749-57. 10.1200\/JCO.2016.67.9613","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001367","article-title":"Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer","volume":"31","author":"Ferreira MP","year":"2017","unstructured":"Ferreira MP, Coghill AE, Chaves CB, et al.. Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer. AIDS. 2017, 31:523-31. 10.1097\/QAD.0000000000001367","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.10.006","article-title":"HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer","volume":"100","author":"Gichangi P","year":"2006","unstructured":"Gichangi P, Bwayo J, Estambale B, Rogo K, Njuguna E, Ojwang S, Temmerman M. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecol Oncol. 2006, 100:405-11. 10.1016\/j.ygyno.2005.10.006","journal-title":"Gynecol Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.01.067","article-title":"Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting","volume":"101","author":"Grover S","year":"2018","unstructured":"Grover S, Bvochora-Nsingo M, Yeager A, et al.. Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting. Int J Radiat Oncol Biol Phys. 2018, 101:201-10. 10.1016\/j.ijrobp.2018.01.067","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002601","article-title":"Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus","volume":"31","author":"Grover S","year":"2021","unstructured":"Grover S, Ning MS, Bale M, et al.. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus. Int J Gynecol Cancer. 2021, 31:1220-7. 10.1136\/ijgc-2021-002601","journal-title":"Int J Gynecol Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2022.101094","article-title":"Stage and outcomes of invasive cervical cancer patients in Botswana: a prospective cohort study from 2013 to 2020","volume":"44","author":"Grover S","year":"2022","unstructured":"Grover S, George J, Tuli S, et al.. Stage and outcomes of invasive cervical cancer patients in Botswana: a prospective cohort study from 2013 to 2020. Gynecol Oncol Rep. 2022, 44:101094. 10.1016\/j.gore.2022.101094","journal-title":"Gynecol Oncol Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaf045","article-title":"Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: Ipabalele study results","volume":"9","author":"Grover S","year":"2025","unstructured":"Grover S, Bhatia R, Zhang S, et al.. Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: Ipabalele study results. JNCI Cancer Spectr. 2025, 9:10.1093\/jncics\/pkaf045","journal-title":"JNCI Cancer Spectr"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-021-00389-w","article-title":"Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana","volume":"16","author":"MacDuffie E","year":"2021","unstructured":"MacDuffie E, Bvochora-Nsingo M, Chiyapo S, et al.. Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana. Infect Agent Cancer. 2021, 16:55. 10.1186\/s13027-021-00389-w","journal-title":"Infect Agent Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1080\/20742835.2015.1083697","article-title":"The impact of HIV infection on women receiving radiation for cervical cancer","volume":"7","author":"Mangena M","year":"2015","unstructured":"Mangena M, Snyman L, Dreyer G, Bassa S, Becker P. The impact of HIV infection on women receiving radiation for cervical cancer. South African J Gynaecol Oncol. 2015, 7:44-51. 10.1080\/20742835.2015.1083697","journal-title":"South African J Gynaecol Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35289","article-title":"Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana","volume":"130","author":"Meghani K","year":"2024","unstructured":"Meghani K, Puri P, Bazzett-Matabele L, et al.. Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana. Cancer. 2024, 130:2462-71. 10.1002\/cncr.35289","journal-title":"Cancer"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26639","article-title":"Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa","volume":"118","author":"Simonds HM","year":"2012","unstructured":"Simonds HM, Wright JD, du Toit N, Neugut AI, Jacobson JS. Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa. Cancer. 2012, 118:2971-9. 10.1002\/cncr.26639","journal-title":"Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000441","article-title":"HIV status and acute hematologic toxicity among patients with cervix cancer undergoing radical chemoradiation","volume":"25","author":"Simonds HM","year":"2015","unstructured":"Simonds HM, Neugut AI, Jacobson JS. HIV status and acute hematologic toxicity among patients with cervix cancer undergoing radical chemoradiation. Int J Gynecol Cancer. 2015, 25:884-90. 10.1097\/IGC.0000000000000441","journal-title":"Int J Gynecol Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.08.038","article-title":"Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort","volume":"151","author":"Simonds HM","year":"2018","unstructured":"Simonds HM, Botha MH, Neugut AI, Van Der Merwe FH, Jacobson JS. Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort. Gynecol Oncol. 2018, 151:215-20. 10.1016\/j.ygyno.2018.08.038","journal-title":"Gynecol Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011592","article-title":"Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer","volume":"97","author":"Vendrell I","year":"2018","unstructured":"Vendrell I, Ferreira AR, Abrunhosa-Branquinho AN, et al.. Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer. Medicine (Baltimore). 2018, 97:e11592. 10.1097\/MD.0000000000011592","journal-title":"Medicine (Baltimore)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1159\/000526270","article-title":"Clinical characteristics and prognosis of cervical cancer patients with human immunodeficiency virus infection: a retrospective study","volume":"87","author":"Wang R","year":"2022","unstructured":"Wang R, Zhang Y, Zhu Y, Li Q. Clinical characteristics and prognosis of cervical cancer patients with human immunodeficiency virus infection: a retrospective study. Gynecol Obstet Invest. 2022, 87:324-32. 10.1159\/000526270","journal-title":"Gynecol Obstet Invest"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2019.100516","article-title":"The association between HIV infection and cervical cancer presentation and survival in Uganda","volume":"31","author":"Wu ES","year":"2020","unstructured":"Wu ES, Urban RR, Krantz EM, et al.. The association between HIV infection and cervical cancer presentation and survival in Uganda. Gynecol Oncol Rep. 2020, 31:100516. 10.1016\/j.gore.2019.100516","journal-title":"Gynecol Oncol Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.12.002","article-title":"Cervical cancer treatment in Rwanda: resource-driven adaptations, quality indicators, and patient outcomes","volume":"164","author":"DeBoer RJ","year":"2022","unstructured":"DeBoer RJ, Umutoni V, Bazzett-Matabele L, et al.. Cervical cancer treatment in Rwanda: resource-driven adaptations, quality indicators, and patient outcomes. Gynecol Oncol. 2022, 164:370-8. 10.1016\/j.ygyno.2021.12.002","journal-title":"Gynecol Oncol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00023","article-title":"How the cervical microbiota contributes to cervical cancer risk in sub-Saharan Africa","volume":"10","author":"Klein C","year":"2020","unstructured":"Klein C, Kahesa C, Mwaiselage J, West JT, Wood C, Angeletti PC. How the cervical microbiota contributes to cervical cancer risk in sub-Saharan Africa. Front Cell Infect Microbiol. 2020, 10:23. 10.3389\/fcimb.2020.00023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref42","unstructured":"UNAIDS. Global HIV\/AIDS statistics. (2022). https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/data-book-2022_en.pdf."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle D","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, et al.. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021, 9:e161-9. 10.1016\/S2214-109X(20)30459-9","journal-title":"Lancet Glob Health"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00439","article-title":"Cancer care disparities: overcoming barriers to cancer control in low- and middle-income countries","volume":"10","author":"Bamodu OA","year":"2024","unstructured":"Bamodu OA, Chung CC. Cancer care disparities: overcoming barriers to cancer control in low- and middle-income countries. JCO Glob Oncol. 2024, 10:e2300439. 10.1200\/GO.23.00439","journal-title":"JCO Glob Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002533","article-title":"Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review","volume":"32","author":"Fenlon JB","year":"2022","unstructured":"Fenlon JB, Rositch AF, Dickey BL, Kimani S, Suneja G. Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review. Int J Gynecol Cancer. 2022, 32:429-35. 10.1136\/ijgc-2021-002533","journal-title":"Int J Gynecol Cancer"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2014.08.005","article-title":"Differential response of the Senegalese sole (Solea senegalensis) Mx promoter to viral infections in two salmonid cell lines","volume":"161","author":"Alvarez-Torres D","year":"2014","unstructured":"Alvarez-Torres D, Alonso MC, Garcia-Rosado E, Collet B, B\u00e9jar J. Differential response of the Senegalese sole (Solea senegalensis) Mx promoter to viral infections in two salmonid cell lines. Vet Immunol Immunopathol. 2014, 161:251-7. 10.1016\/j.vetimm.2014.08.005","journal-title":"Vet Immunol Immunopathol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres HA","year":"2014","unstructured":"Torres HA, Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy. Clin Infect Dis. 2014, 59:106-14. 10.1093\/cid\/ciu174","journal-title":"Clin Infect Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019833038","article-title":"Managing pharmacotherapy in people living with HIV and concomitant malignancy","volume":"53","author":"Olin JL","year":"2019","unstructured":"Olin JL, Klibanov O, Chan A, Spooner LM. Managing pharmacotherapy in people living with HIV and concomitant malignancy. Ann Pharmacother. 2019, 53:812-32. 10.1177\/1060028019833038","journal-title":"Ann Pharmacother"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00218","article-title":"Access to radiation therapy and related clinical outcomes in patients with cervical and breast cancer across sub-Saharan Africa: a systematic review","volume":"9","author":"Beltr\u00e1n Ponce SE","year":"2023","unstructured":"Beltr\u00e1n Ponce SE, Abunike SA, Bikomeye JC, et al.. Access to radiation therapy and related clinical outcomes in patients with cervical and breast cancer across sub-Saharan Africa: a systematic review. JCO Glob Oncol. 2023, 9:e2200218. 10.1200\/GO.22.00218","journal-title":"JCO Glob Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002461","article-title":"Gynecological radiation oncology in sub-Saharan Africa: status, problems and considerations for the future","volume":"32","author":"Lombe D","year":"2022","unstructured":"Lombe D, M'ule BC, Msadabwe SC, Chanda E. Gynecological radiation oncology in sub-Saharan Africa: status, problems and considerations for the future. Int J Gynecol Cancer. 2022, 32:451-6. 10.1136\/ijgc-2021-002461","journal-title":"Int J Gynecol Cancer"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00376","article-title":"Modern radiotherapy technology: obstacles and opportunities to access in low- and middle-income countries","volume":"8","author":"Maitre P","year":"2022","unstructured":"Maitre P, Krishnatry R, Chopra S, et al.. Modern radiotherapy technology: obstacles and opportunities to access in low- and middle-income countries. JCO Glob Oncol. 2022, 8:e2100376. 10.1200\/GO.21.00376","journal-title":"JCO Glob Oncol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00038-X","article-title":"Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities","volume":"25","author":"Abdel-Wahab M","year":"2024","unstructured":"Abdel-Wahab M, Coleman CN, Eriksen JG, et al.. Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities. Lancet Oncol. 2024, 25:e270-80. 10.1016\/S1470-2045(24)00038-X","journal-title":"Lancet Oncol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-07103-5","article-title":"Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)","volume":"30","author":"Link H","year":"2022","unstructured":"Link H. Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF). Support Care Cancer. 2022, 30:7067-77. 10.1007\/s00520-022-07103-5","journal-title":"Support Care Cancer"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002420","article-title":"Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV","volume":"85","author":"Grover S","year":"2020","unstructured":"Grover S, Mehta P, Wang Q, et al.. Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV. J Acquir Immune Defic Syndr. 2020, 85:201-8. 10.1097\/QAI.0000000000002420","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-021-00542-5","article-title":"Impact of antiretroviral therapy on cancer treatment outcomes among people living with HIV in low-and middle-income countries: a systematic review","volume":"18","author":"Monta\u00f1o MA","year":"2021","unstructured":"Monta\u00f1o MA, Chagomerana MB, Borok M, Painschab M, Uldrick TS, Bender Ignacio RA. Impact of antiretroviral therapy on cancer treatment outcomes among people living with HIV in low-and middle-income countries: a systematic review. Curr HIV\/AIDS Rep. 2021, 18:105-16. 10.1007\/s11904-021-00542-5","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.101924","article-title":"High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer","volume":"35","author":"Mei X","year":"2025","unstructured":"Mei X, Fobian SF, IJff M, et al.. High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer. Int J Gynecol Cancer. 2025, 35:101924. 10.1016\/j.ijgc.2025.101924","journal-title":"Int J Gynecol Cancer"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189106","article-title":"Emerging biomarkers and molecular targets for precision medicine in cervical cancer","volume":"1879","author":"Garg P","year":"2024","unstructured":"Garg P, Krishna M, Subbalakshmi AR, et al.. Emerging biomarkers and molecular targets for precision medicine in cervical cancer. Biochim Biophys Acta Rev Cancer. 2024, 1879:189106. 10.1016\/j.bbcan.2024.189106","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-022-00551-9","article-title":"Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review","volume":"13","author":"Arip M","year":"2022","unstructured":"Arip M, Tan LF, Jayaraj R, Abdullah M, Rajagopal M, Selvaraja M. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. Discov Oncol. 2022, 13:91. 10.1007\/s12672-022-00551-9","journal-title":"Discov Oncol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.2024S115","article-title":"Beyond the diagnosis: gender disparities in the social and emotional impact of cancer","volume":"70","author":"Pra\u00e7a MS","year":"2024","unstructured":"Pra\u00e7a MS, Sousa FT, C\u00e2ndido EB, Lamaita RM, Wender MC, Silva Filho AL. Beyond the diagnosis: gender disparities in the social and emotional impact of cancer. Rev Assoc Med Bras (1992). 2024, 70:e2024S115. 10.1590\/1806-9282.2024S115","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2256-7","article-title":"Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda","volume":"16","author":"Tapela NM","year":"2016","unstructured":"Tapela NM, Mpunga T, Hedt-Gauthier B, et al.. Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda. BMC Cancer. 2016, 16:237. 10.1186\/s12885-016-2256-7","journal-title":"BMC Cancer"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3468","article-title":"A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision","volume":"9","author":"Nakalembe M","year":"2020","unstructured":"Nakalembe M, Makanga P, Kambugu A, Laker-Oketta M, Huchko MJ, Martin J. A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision. Cancer Med. 2020, 9:8701-12. 10.1002\/cam4.3468","journal-title":"Cancer Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181156","article-title":"Integrating cervical cancer with HIV healthcare services: a systematic review","volume":"12","author":"Sigfrid L","year":"2017","unstructured":"Sigfrid L, Murphy G, Haldane V, et al.. Integrating cervical cancer with HIV healthcare services: a systematic review. PLoS One. 2017, 12:e0181156. 10.1371\/journal.pone.0181156","journal-title":"PLoS One"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4017","article-title":"Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review","volume":"10","author":"Lakomy DS","year":"2021","unstructured":"Lakomy DS, Wu J, Lombe D, et al.. Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review. Cancer Med. 2021, 10:4206-20. 10.1002\/cam4.4017","journal-title":"Cancer Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2024.2408004","article-title":"Drug-drug interactions in HIV-infected patients receiving chemotherapy","volume":"21","author":"Branch C","year":"2025","unstructured":"Branch C, Parson-Martinez J, Cory TJ. Drug-drug interactions in HIV-infected patients receiving chemotherapy. Expert Opin Drug Metab Toxicol. 2025, 21:15-27. 10.1080\/17425255.2024.2408004","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.12.034","article-title":"Improving access to radiation therapy globally to meet World Health Organization goals to eliminate cervical cancer","volume":"116","author":"Lin LL","year":"2023","unstructured":"Lin LL, Msadabwe SC, Chiao E. Improving access to radiation therapy globally to meet World Health Organization goals to eliminate cervical cancer. Int J Radiat Oncol Biol Phys. 2023, 116:459-62. 10.1016\/j.ijrobp.2022.12.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001452","article-title":"The role of community health workers in cervical cancer screening in low-income and middle-income countries: a systematic scoping review of the literature","volume":"4","author":"O'Donovan J","year":"2019","unstructured":"O'Donovan J, O'Donovan C, Nagraj S. The role of community health workers in cervical cancer screening in low-income and middle-income countries: a systematic scoping review of the literature. BMJ Glob Health. 2019, 4:e001452. 10.1136\/bmjgh-2019-001452","journal-title":"BMJ Glob Health"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33841","article-title":"Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa","volume":"150","author":"Ibrahim Khalil A","year":"2022","unstructured":"Ibrahim Khalil A, Mpunga T, Wei F, et al.. Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa. Int J Cancer. 2022, 150:761-72. 10.1002\/ijc.33841","journal-title":"Int J Cancer"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2023.05.006","article-title":"Improving outcomes for adolescents and young adults living with\u00a0hiv","volume":"73","year":"2023","unstructured":"Improving outcomes for adolescents and young adults living with\u00a0hiv. J Adolesc Health. 2023, 73.605-9. 10.1016\/j.jadohealth.2023.05.006","journal-title":"J Adolesc Health"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.07.1632","article-title":"Stage and outcomes of cervical cancer with or without HIV infection in Botswana 2013-2020","volume":"111","author":"George J","year":"2021","unstructured":"George J, Tuli S, Monare B, et al.. Stage and outcomes of cervical cancer with or without HIV infection in Botswana 2013-2020. Int J Radiat Oncol. 2021, 111:612-3. 10.1016\/j.ijrobp.2021.07.1632","journal-title":"Int J Radiat Oncol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly H","year":"2018","unstructured":"Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018, 5:e45-58. 10.1016\/S2352-3018(17)30149-2","journal-title":"Lancet HIV"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02060","article-title":"Immunotherapy in people with HIV and cancer","volume":"10","author":"Puronen CE","year":"2019","unstructured":"Puronen CE, Ford ES, Uldrick TS. Immunotherapy in people with HIV and cancer. Front Immunol. 2019, 10:2060. 10.3389\/fimmu.2019.02060","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420364-cervical-cancer-outcomes-and-toxicity-in-hiv-positive-women-treated-with-radiation-or-chemoradiation-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:57:24Z","timestamp":1766426244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420364-cervical-cancer-outcomes-and-toxicity-in-hiv-positive-women-treated-with-radiation-or-chemoradiation-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":71,"URL":"https:\/\/doi.org\/10.7759\/cureus.99855","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}